Nanosonics | NAN - 营业费用



金融业
股票价格
AUD 2.99
资产
AUD 279.25M
现金及等价物
AUD 161.29M
销售成本
AUD 24.23M
流动资产
AUD 234.13M
流动负债
AUD 36.59M
债务
AUD 7.69M
EBIT
AUD 9.12M
EBITDA
AUD 12.49M
员工
470
EPS每股收益
AUD 0.03
股本和储备
AUD 219.69M
销售毛利
AUD 78.01M
债务利息支出
AUD 779K
利息收入
AUD 2.89M
贷款资金
AUD 3.21M
市值
AUD 945.04M
净收入
AUD 9.64M
营业费用
AUD 93.11M
营业利润
AUD 9.12M
普通股股本
AUD 303.35M
PE价格收益
65.33
税前利润
AUD 11.39M
销售收入
AUD 102.23M
销售和管理费用
AUD 53.78M
股票
AUD 18.63M
贸易债权人
AUD 12.22M
应收帐款人
AUD 46.45M


营业费用 更改 日
Alcidion AUD 23.27M 565K 2025-12
Ansell USD 880.1M 465.65M 2025-12
Avita Medical AUD 28.02M 1.55M 2025-12
Cochlear AUD 914.9M 454.8M 2025-12
CSL USD 5.7B 2.82B 2025-12
Fisher & Paykel Healthcare NZD 869.6M 67.2M 2026-06
Healius AUD 684.9M 261.2M 2024-12
Integral Diagnostics AUD 219.16M 66.76M 2024-06
Mayne Pharma AUD 103.54M 9.39M 2024-06
Polynovo AUD 68.22M 1.24M 2025-12
Pro Medicus AUD 31.46M 2.65M 2026-06
Ramsay Health Care AUD 8.8B 83.5M 2025-12
ResMed USD 931.6M 9.09M 2026-03
Somnomed AUD 47.82M 4.98M 2023-06
Sonic Healthcare AUD 4.23B 2.14B 2024-12